Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 607

GenSight narrows ambitions by postponing IPO

The Novartis-backed eye disease therapy developer set the range last month for an initial public offering sized at up to $65m.

Nov 9, 2015

Swansea spinouts score with Swansea City

Shareholders in football team Swansea City announce intention to co-invest along with Swansea University Innovation Fund.

Nov 6, 2015

Reaction Engines darts to $30.8m

BAE Systems has acquired a 20% stake in the company, which is working on an engine that would cut travel time from the UK to Australia to just four hours.

Nov 4, 2015
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here